Skip to main
University-wide Navigation

2 Markey cancer researchers win V Foundation awards

Ka-wing Fong, Ph.D., and Eric Rellinger, M.D., were named V Scholars by the V Foundation for Cancer Research and will each receive $600,000 to fund their individual cancer research projects.

Telehealth supports retention in treatment for opioid use disorder, UK study finds

Published in JAMA Network Open, new findings are adding to a growing body of evidence demonstrating positive outcomes associated with telemedicine for treating opioid use disorder.

Markey researchers develop new resource to aid in cancer surveillance at US cancer centers

A recent article published in Cancer Epidemiology, Biomarkers & Prevention documents Cancer InFocus' development.

UK’s Kolesar 1 of 9 innovators selected for NIH-funded entrepreneurship program

One of the University of Kentucky Markey Cancer Center’s leading researchers has been selected to participate in the inaugural cohort of the National Institutes of Health (NIH) funded Institutional Development Award (IDeA) Regional Entrepreneurship Development (I-RED) Program.

UK awarded $3.4 million to lead equity initiative in drug abuse research

The University of Kentucky has been selected as the nationwide coordination center for a National Institutes of Health (NIH) initiative, supported by a $3.4 million, five-year grant.

UK awarded $19 million to research tobacco regulation in Appalachia, inform FDA

The University of Kentucky will be home to a new research center focused on tobacco regulations in the Commonwealth named the Appalachian Tobacco Regulatory Science Team (AppalTRuST).

Markey’s ACTION program gets $2 million grant renewal from NCI

Launched in 2016, ACTION is a cancer education and training program aimed at high school and undergraduate students from Appalachian Kentucky.

UK researchers lead multidisciplinary project for next-generation organic semiconductors

A multi-institutional collaboration led by UK researchers was one of 37 teams to receive National Science Foundation funding as part of the Designing Materials to Revolutionize and Engineer our Future (DMREF) program.

Precision medicine, Markey collaboration delivers hope to Bowling Green patient

Collaborations with community hospitals across Kentucky give cancer patients access to the latest treatments and clinical trials closer to home.